These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16314757)

  • 21. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease.
    Rebeck GW; Cheung BS; Growdon WB; Deng A; Akuthota P; Locascio J; Greenberg SM; Hyman BT
    Neurosci Lett; 1999 Sep; 272(3):155-8. PubMed ID: 10505604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
    O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
    Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between ACT polymorphism and Alzheimer's disease.
    Kamboh MI; Aston CE; Dekosky ST
    Neurology; 1998 Feb; 50(2):574-6. PubMed ID: 9508644
    [No Abstract]   [Full Text] [Related]  

  • 24. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease.
    Chen L; Baum L; Ng HK; Chan LY; Sastre I; Artíga MJ; Valdivieso F; Bullido MJ; Chiu HF; Pang CP
    Neurosci Lett; 1999 Jul; 269(3):173-7. PubMed ID: 10454160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia.
    Bullido MJ; Artiga MJ; Recuero M; Sastre I; García MA; Aldudo J; Lendon C; Han SW; Morris JC; Frank A; Vázquez J; Goate A; Valdivieso F
    Nat Genet; 1998 Jan; 18(1):69-71. PubMed ID: 9425904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.
    Fukumoto H; Ingelsson M; Gårevik N; Wahlund LO; Nukina N; Yaguchi Y; Shibata M; Hyman BT; Rebeck GW; Irizarry MC
    Exp Neurol; 2003 Sep; 183(1):249-53. PubMed ID: 12957508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation at the APOE -491 promoter locus is associated with altered brain levels of apolipoprotein E.
    Laws SM; Hone E; Taddei K; Harper C; Dean B; McClean C; Masters C; Lautenschlager N; Gandy SE; Martins RN
    Mol Psychiatry; 2002; 7(8):886-90. PubMed ID: 12232782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers.
    Matsubara-Tsutsui M; Yamagata H; Morishima A; Nakura J; Mitsuda N; Kamino K; Kondo I; Miki T
    Intern Med; 2002 Oct; 41(10):823-8. PubMed ID: 12413003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene.
    Feuk L; Prince JA; Breen G; Emahazion T; Carothers A; St Clair D; Brookes AJ
    Hum Genet; 2000 Oct; 107(4):391-6. PubMed ID: 11129341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha1-antichymotrypsin polymorphism in Japanese cases of Alzheimer's disease.
    Yoshizawa T; Yamakawa-Kobayashi K; Hamaguchi H; Shoji S
    J Neurol Sci; 1997 Nov; 152(2):136-9. PubMed ID: 9415533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease.
    Cheng D; Huang R; Lanham IS; Cathcart HM; Howard M; Corder EH; Poduslo SE
    J Med Genet; 2005 Feb; 42(2):129-31. PubMed ID: 15689450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study.
    McCusker SM; Curran MD; Dynan KB; McCullagh CD; Urquhart DD; Middleton D; Patterson CC; McIlroy SP; Passmore AP
    Lancet; 2001 Feb; 357(9254):436-9. PubMed ID: 11273064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SREBP-1a polymorphism influences the risk of Alzheimer's disease in carriers of the ApoE4 allele.
    Spell C; Kölsch H; Lütjohann D; Kerksiek A; Hentschel F; Damian M; von Bergmann K; Rao ML; Maier W; Heun R
    Dement Geriatr Cogn Disord; 2004; 18(3-4):245-9. PubMed ID: 15286454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia?
    Thome J; Gewirtz JC; Sakai N; Zachariou V; Retz-Junginger P; Retz W; Duman RS; Rösler M
    Neurosci Lett; 1999 Oct; 274(1):37-40. PubMed ID: 10530514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.
    Lambert JC; Pasquier F; Cottel D; Frigard B; Amouyel P; Chartier-Harlin MC
    Hum Mol Genet; 1998 Mar; 7(3):533-40. PubMed ID: 9467014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.
    Lambert JC; Araria-Goumidi L; Myllykangas L; Ellis C; Wang JC; Bullido MJ; Harris JM; Artiga MJ; Hernandez D; Kwon JM; Frigard B; Petersen RC; Cumming AM; Pasquier F; Sastre I; Tienari PJ; Frank A; Sulkava R; Morris JC; St Clair D; Mann DM; Wavrant-DeVrièze F; Ezquerra-Trabalon M; Amouyel P; Hardy J; Haltia M; Valdivieso F; Goate AM; Pérez-Tur J; Lendon CL; Chartier-Harlin MC
    Neurology; 2002 Jul; 59(1):59-66. PubMed ID: 12105308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is MTHFR polymorphism a risk factor for Alzheimer's disease like APOE?
    Fernandez LL; Scheibe RM
    Arq Neuropsiquiatr; 2005 Mar; 63(1):1-6. PubMed ID: 15830056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The --491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease.
    Alvarez-Arcaya A; Combarros O; Llorca J; Sánchez-Guerra M; Berciano J; Fernández-Luna JL
    Neurosci Lett; 2001 May; 304(3):204-8. PubMed ID: 11343837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.